Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 926

    1.

    Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome.

    Splinter MY.

    Ann Pharmacother. 2007 Feb;41(2):285-95. Epub 2007 Jan 9. Review.PMID: 17213296 [PubMed - indexed for MEDLINE]Related articles

    2.

    Rotigotine transdermal system for the treatment of Parkinson's disease.

    Pham DQ, Nogid A.

    Clin Ther. 2008 May;30(5):813-24. Review.PMID: 18555929 [PubMed - indexed for MEDLINE]Related articles

    3.

    Rotigotine: a novel dopamine agonist for the transdermal treatment of Parkinson's disease.

    Zareba G.

    Drugs Today (Barc). 2006 Jan;42(1):21-8. Review.PMID: 16511608 [PubMed - indexed for MEDLINE]Related articles

    4.

    Rotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndrome.

    Kenney C, Jankovic J.

    Expert Opin Pharmacother. 2007 Jun;8(9):1329-35. Review. Erratum in: Expert Opin Pharmacother. 2007 Oct;8(14):2447-8. PMID: 17563266 [PubMed - indexed for MEDLINE]Related articles

    5.

    Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease.

    Metman LV, Gillespie M, Farmer C, Bibbiani F, Konitsiotis S, Morris M, Shill H, Bara-Jimenez W, Mouradian MM, Chase TN.

    Clin Neuropharmacol. 2001 May-Jun;24(3):163-9.PMID: 11391128 [PubMed - indexed for MEDLINE]Related articles

    6.

    Transdermal rotigotine: a new non-ergot dopamine agonist for the treatment of Parkinson's disease.

    Naidu Y, Chaudhuri KR.

    Expert Opin Drug Deliv. 2007 Mar;4(2):111-8. Review.PMID: 17335409 [PubMed - indexed for MEDLINE]Related articles

    7.

    One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome.

    Oertel WH, Benes H, Garcia-Borreguero D, Geisler P, Högl B, Trenkwalder C, Tacken I, Schollmayer E, Kohnen R, Stiasny-Kolster K; Rotigotine SP710 Study Group.

    Sleep Med. 2008 Dec;9(8):865-73. Epub 2008 Aug 26.PMID: 18753003 [PubMed - indexed for MEDLINE]Related articles

    8.

    Rotigotine: Parkinson's disease: a step backward.

    [No authors listed]

    Prescrire Int. 2008 Apr;17(94):60.PMID: 18516813 [PubMed - indexed for MEDLINE]Related articles

    9.

    Rotigotine Schwarz Pharma.

    Mucke HA.

    IDrugs. 2003 Sep;6(9):894-9. Review.PMID: 12964070 [PubMed - indexed for MEDLINE]Related articles

    10.

    Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial.

    Trenkwalder C, Benes H, Poewe W, Oertel WH, Garcia-Borreguero D, de Weerd AW, Ferini-Strambi L, Montagna P, Odin P, Stiasny-Kolster K, Högl B, Chaudhuri KR, Partinen M, Schollmayer E, Kohnen R; SP790 Study Group.

    Lancet Neurol. 2008 Jul;7(7):595-604.PMID: 18515185 [PubMed - indexed for MEDLINE]Related articles

    11.

    Rotigotine: in Parkinson's disease.

    Reynolds NA, Wellington K, Easthope SE.

    CNS Drugs. 2005;19(11):973-81. Review.PMID: 16268667 [PubMed - indexed for MEDLINE]Related articles

    12.

    Spotlight on rotigotine in Parkinson's disease.

    Baldwin CM, Keating GM.

    Drugs Aging. 2008;25(2):175-7.PMID: 18257604 [PubMed - indexed for MEDLINE]Related articles

    13.

    Rotigotine transdermal patch: in restless legs syndrome.

    Baldwin CM, Keating GM.

    CNS Drugs. 2008;22(10):797-806. Review.PMID: 18788832 [PubMed - indexed for MEDLINE]Related articles

    14.

    Rotigotine transdermal delivery for the treatment of Parkinson's disease.

    Rascol O, Perez-Lloret S.

    Expert Opin Pharmacother. 2009 Mar;10(4):677-91. Review.PMID: 19239399 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease.

    Baldwin CM, Keating GM.

    CNS Drugs. 2007;21(12):1039-55. Review.PMID: 18020483 [PubMed - indexed for MEDLINE]Related articles

    16.

    New pharmacotherapy for Parkinson's disease.

    Gottwald MD, Bainbridge JL, Dowling GA, Aminoff MJ, Alldredge BK.

    Ann Pharmacother. 1997 Oct;31(10):1205-17. Review.PMID: 9337447 [PubMed - indexed for MEDLINE]Related articles

    17.

    Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial.

    Poewe WH, Rascol O, Quinn N, Tolosa E, Oertel WH, Martignoni E, Rupp M, Boroojerdi B; SP 515 Investigators.

    Lancet Neurol. 2007 Jun;6(6):513-20.PMID: 17509486 [PubMed - indexed for MEDLINE]Related articles

    18.

    Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole.

    Giladi N, Boroojerdi B, Korczyn AD, Burn DJ, Clarke CE, Schapira AH; SP513 investigators.

    Mov Disord. 2007 Dec;22(16):2398-404.PMID: 17935234 [PubMed - indexed for MEDLINE]Related articles

    19.

    Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson disease.

    LeWitt PA, Boroojerdi B, MacMahon D, Patton J, Jankovic J.

    Clin Neuropharmacol. 2007 Sep-Oct;30(5):256-65.PMID: 17909303 [PubMed - indexed for MEDLINE]Related articles

    20.

    A controlled trial of rotigotine monotherapy in early Parkinson's disease.

    Parkinson Study Group.

    Arch Neurol. 2003 Dec;60(12):1721-8.PMID: 14676046 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data